Decile Access: Fay Ventures
Smart Capital for Seed - Stage MedTech Startups
Overview
Fay Ventures Fund Description
Fay Ventures is raising a $1MM seed fund to back US MedTech companies positioned at the intersection of market demand and regulatory tailwinds.
Market Opportunity
The MedTech landscape is shifting fundamentally. Patients are driving demand for earlier detection, prevention is moving from "nice idea" to reimbursed reality, and clinician-driven innovation is accelerating. Patient preference for at-home, low-friction care is reshaping the market. Simultaneously, the FDA has enhanced programs to actively accelerate and de-risk MedTech regulatory pathways—creating an unprecedented window for early-stage innovation.
Our Edge
We leverage a proprietary 800-member MedTech ecosystem through Amplify MedTech to support portfolio companies with expert introductions, hands-on mentorship, talent recruitment, and investor connections. Our GP brings nearly 20 years of MedTech expertise, having advised 150+ startups including 5 that raised $50MM+ follow-on rounds and 3 successful exits.
Investment Focus
We target seed-stage MedTech companies with product-market fit, a working prototype, and initiated FDA conversations. Our $50-100K checks support 10-15 companies, positioning us as a founder-friendly partner who understands the regulatory and clinical realities of healthcare innovation.
Returns Strategy
We employ a staggered investment approach across early-stage seed and seed+ companies, targeting first exits within 3 years with ongoing liquidity events thereafter.
Venture capital investing involves substantial risk, including risk of loss of all capital invested. Achievement of investment objectives cannot be guaranteed. Past performance does not guarantee future results. To see additional risk factors and considerations, please see Risk Factors and Investment Considerations.
No content hosted on this website is an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are made only to accredited investors pursuant to the formal offering documents, which describe the terms and other important information that must be carefully considered before an investment is made. We require verification of accreditation for all investors.
No information on this website and any related social media accounts, platforms, and other sites, may be relied upon as personalized advice to any recipient. These materials are provided for informational purposes only. Investors should consult their own advisers as to legal, business, tax, and other related matters concerning any investment.
Certain information herein constitutes "forward-looking statements" and you should not place undue reliance on these forward-looking statements.
